Browse Medikamente durchsuchen

90 Drugs

Aprovel 150 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 150 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 300 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 300 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 75 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 75 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
CoAprovel 150 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
CoAprovel 150 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
CoAprovel 300 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
CoAprovel 300 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
CoAprovel 300 mg/25 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Ifirmacombi 150 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Hydrochlorothiazide, Irbesartan
Ifirmacombi 300 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Hydrochlorothiazide, Irbesartan
Ifirmacombi 300 mg/25 mg film-coated tablets
- admission:
  Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Hydrochlorothiazide, Irbesartan
Ifirmasta 150 mg film-coated tablets
- admission:
  Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Irbesartan
Ifirmasta 300 mg film-coated tablets
- admission:
  Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Irbesartan
Ifirmasta 75 mg film-coated tablets
- admission:
  Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 150 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 150 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 300 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 300 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 300 mg/25 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Teva 150 mg film-coated tablets
- admission:
  Great Britain
- Producer: Teva Pharma B.V.
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Irbesartan Teva 300 mg film-coated tablets
- admission:
  Great Britain
- Producer: Teva Pharma B.V.
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Irbesartan Teva 75 mg film-coated tablets
- admission:
  Great Britain
- Producer: Teva Pharma B.V.
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Irbesartan Winthrop 150 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan

Pages